Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands |
Total Plug Power Stockholders' Equity |
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income/(Loss) |
Treasury Stock |
Accumulated Deficit |
Non-controlling Interests |
Total |
| Beginning Balance at Dec. 31, 2024 |
$ 1,734,137
|
$ 9,342
|
$ 8,430,537
|
$ (2,502)
|
$ (108,795)
|
$ (6,594,445)
|
$ 73,619
|
$ 1,807,756
|
| Beginning Balance, shares at Dec. 31, 2024 |
|
934,126,897
|
|
|
|
|
|
|
| Treasury Stock, Beginning Balance, shares at Dec. 31, 2024 |
|
|
|
|
20,230,043,000
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
(196,656)
|
|
|
|
|
(196,656)
|
(203)
|
(196,859)
|
| Other comprehensive income (loss) |
(2,729)
|
|
|
(2,729)
|
|
|
|
(2,729)
|
| Stock-based compensation |
11,087
|
$ 15
|
11,072
|
|
|
|
|
11,087
|
| Stock-based compensation, shares |
|
1,545,763
|
|
|
|
|
|
|
| Public offerings, common stock, net of issuance costs |
276,053
|
$ 517
|
275,536
|
|
|
|
|
276,053
|
| Public offerings, common stock, net of issuance costs, shares |
|
51,654,177
|
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
|
$ (2)
|
2
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
(157,005)
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(49)
|
|
|
|
$ (49)
|
|
|
(49)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
27,027,000
|
|
|
|
| Provision for common stock warrants |
7,049
|
|
7,049
|
|
|
|
|
7,049
|
| Additional paid-in capital due to contributions to consolidated VIE |
(1,971)
|
|
(1,971)
|
|
|
|
1,971
|
|
| Principal payment of convertible debenture settled in common stock |
30,279
|
$ 105
|
30,174
|
|
|
|
|
30,279
|
| Principal payment of convertible debenture settled in common stock, shares |
|
10,440,906
|
|
|
|
|
|
|
| Ending Balance at Mar. 31, 2025 |
1,857,200
|
$ 9,977
|
8,752,399
|
(5,231)
|
$ (108,844)
|
(6,791,101)
|
75,387
|
1,932,587
|
| Ending Balance, shares at Mar. 31, 2025 |
|
997,610,738
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Mar. 31, 2025 |
|
|
|
|
20,257,070,000
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
1,734,137
|
$ 9,342
|
8,430,537
|
(2,502)
|
$ (108,795)
|
(6,594,445)
|
73,619
|
1,807,756
|
| Beginning Balance, shares at Dec. 31, 2024 |
|
934,126,897
|
|
|
|
|
|
|
| Treasury Stock, Beginning Balance, shares at Dec. 31, 2024 |
|
|
|
|
20,230,043,000
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
|
|
|
|
|
|
|
(789,091)
|
| Ending Balance at Sep. 30, 2025 |
1,416,629
|
$ 12,194
|
8,886,531
|
3,775
|
$ (105,802)
|
(7,380,069)
|
81,992
|
1,498,621
|
| Ending Balance, shares at Sep. 30, 2025 |
|
1,219,328,594
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Sep. 30, 2025 |
|
|
|
|
18,816,602,000
|
|
|
|
| Beginning Balance at Mar. 31, 2025 |
1,857,200
|
$ 9,977
|
8,752,399
|
(5,231)
|
$ (108,844)
|
(6,791,101)
|
75,387
|
1,932,587
|
| Beginning Balance, shares at Mar. 31, 2025 |
|
997,610,738
|
|
|
|
|
|
|
| Treasury Stock, Beginning Balance, shares at Mar. 31, 2025 |
|
|
|
|
20,257,070,000
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
(227,099)
|
|
|
|
|
(227,099)
|
(1,628)
|
(228,727)
|
| Other comprehensive income (loss) |
8,709
|
|
|
8,709
|
|
|
|
8,709
|
| Stock-based compensation |
13,080
|
$ 29
|
13,051
|
|
|
|
|
13,080
|
| Stock-based compensation, shares |
|
2,947,415
|
|
|
|
|
|
|
| Warrants issued with 15.00% Secured Debenture |
6,069
|
|
6,069
|
|
|
|
|
6,069
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
|
$ (1)
|
1
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
(133,820)
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(158)
|
|
|
|
$ (158)
|
|
|
(158)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
172,896,000
|
|
|
|
| Provision for common stock warrants |
9,164
|
|
9,164
|
|
|
|
|
9,164
|
| Additional paid-in capital due to contributions to consolidated VIE |
(6,044)
|
|
(6,044)
|
|
|
|
6,044
|
|
| Contributions by non-controlling interest |
|
|
|
|
|
|
3,091
|
3,091
|
| Principal payment of convertible debenture settled in common stock |
20,006
|
$ 283
|
19,723
|
|
|
|
|
20,006
|
| Principal payment of convertible debenture settled in common stock, shares |
|
28,295,151
|
|
|
|
|
|
|
| Exercises of pre-funded warrants |
139
|
$ 1,389
|
(1,250)
|
|
|
|
|
139
|
| Exercises of pre-funded warrants, shares |
|
138,930,464
|
|
|
|
|
|
|
| Expiration of common stock forward and retirement of related treasury stock |
|
$ (19)
|
(3,679)
|
|
$ 3,698
|
|
|
|
| Expiration of common stock forward and retirement of related treasury stock, shares |
|
(1,935,900)
|
|
|
(1,935,900,000)
|
|
|
|
| Ending Balance at Jun. 30, 2025 |
1,681,066
|
$ 11,658
|
8,789,434
|
3,478
|
$ (105,304)
|
(7,018,200)
|
82,894
|
1,763,960
|
| Ending Balance, shares at Jun. 30, 2025 |
|
1,165,714,048
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Jun. 30, 2025 |
|
|
|
|
18,494,066,000
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
(361,869)
|
|
|
|
|
(361,869)
|
(1,636)
|
(363,505)
|
| Other comprehensive income (loss) |
297
|
|
|
297
|
|
|
|
297
|
| Stock-based compensation |
12,237
|
$ 15
|
12,222
|
|
|
|
|
12,237
|
| Stock-based compensation, shares |
|
1,476,235
|
|
|
|
|
|
|
| Public offerings, common stock, net of issuance costs |
46,301
|
$ 294
|
46,007
|
|
|
|
|
46,301
|
| Public offerings, common stock, net of issuance costs, shares |
|
29,419,352
|
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
11
|
$ 12
|
(1)
|
|
|
|
|
11
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
(1,218,959)
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(498)
|
|
|
|
$ (498)
|
|
|
(498)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
322,536,000
|
|
|
|
| Provision for common stock warrants |
9,588
|
|
9,588
|
|
|
|
|
9,588
|
| Additional paid-in capital due to contributions to consolidated VIE |
41
|
|
41
|
|
|
|
(41)
|
|
| Contributions by non-controlling interest |
|
|
|
|
|
|
775
|
775
|
| Exercises of 15% Secured Debenture Warrant |
29,455
|
$ 215
|
29,240
|
|
|
|
|
29,455
|
| Exercises of 15% Secured Debenture Warrant, shares |
|
21,500,000
|
|
|
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
1,416,629
|
$ 12,194
|
8,886,531
|
3,775
|
$ (105,802)
|
(7,380,069)
|
81,992
|
1,498,621
|
| Ending Balance, shares at Sep. 30, 2025 |
|
1,219,328,594
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Sep. 30, 2025 |
|
|
|
|
18,816,602,000
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
978,069
|
$ 13,943
|
9,186,314
|
6,796
|
$ (2,945)
|
(8,226,039)
|
25,245
|
$ 1,003,314
|
| Beginning Balance, shares at Dec. 31, 2025 |
|
1,394,241,538
|
|
|
|
|
|
1,394,241,538
|
| Treasury Stock, Beginning Balance, shares at Dec. 31, 2025 |
|
|
|
|
970,588
|
|
|
970,588
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
(245,304)
|
|
|
|
|
(245,304)
|
(733)
|
$ (246,037)
|
| Other comprehensive income (loss) |
(3,354)
|
|
|
(3,354)
|
|
|
|
(3,354)
|
| Stock-based compensation |
13,938
|
$ 14
|
13,924
|
|
|
|
|
13,938
|
| Stock-based compensation, shares |
|
1,432,765
|
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
90
|
|
90
|
|
|
|
|
90
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
(30,913)
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(37)
|
|
|
|
$ (37)
|
|
|
(37)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
16,907
|
|
|
|
| Provision for common stock warrants |
5,675
|
|
5,675
|
|
|
|
|
5,675
|
| Additional paid-in capital due to contributions to consolidated VIE |
733
|
|
733
|
|
|
|
(733)
|
|
| Contributions by non-controlling interest |
|
|
|
|
|
|
300
|
300
|
| Ending Balance at Mar. 31, 2026 |
749,810
|
$ 13,957
|
9,206,736
|
3,442
|
$ (2,982)
|
(8,471,343)
|
24,079
|
773,889
|
| Ending Balance, shares at Mar. 31, 2026 |
|
1,395,643,390
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Mar. 31, 2026 |
|
|
|
|
987,495
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
978,069
|
$ 13,943
|
9,186,314
|
6,796
|
$ (2,945)
|
(8,226,039)
|
25,245
|
$ 1,003,314
|
| Beginning Balance, shares at Dec. 31, 2025 |
|
1,394,241,538
|
|
|
|
|
|
1,394,241,538
|
| Treasury Stock, Beginning Balance, shares at Dec. 31, 2025 |
|
|
|
|
970,588
|
|
|
970,588
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
|
|
|
|
|
|
|
$ (337,102)
|
| Ending Balance at Sep. 30, 2026 |
705,896
|
$ 14,001
|
9,254,997
|
1,265
|
$ (4,583)
|
(8,559,784)
|
5,485
|
$ 711,381
|
| Ending Balance, shares at Sep. 30, 2026 |
|
1,400,004,604
|
|
|
|
|
|
1,400,004,604
|
| Treasury Stock, Ending Balance, shares at Sep. 30, 2026 |
|
|
|
|
1,729,151
|
|
|
1,729,151
|
| Beginning Balance at Mar. 31, 2026 |
749,810
|
$ 13,957
|
9,206,736
|
3,442
|
$ (2,982)
|
(8,471,343)
|
24,079
|
$ 773,889
|
| Beginning Balance, shares at Mar. 31, 2026 |
|
1,395,643,390
|
|
|
|
|
|
|
| Treasury Stock, Beginning Balance, shares at Mar. 31, 2026 |
|
|
|
|
987,495
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
(188,207)
|
|
|
|
|
(188,207)
|
(1,895)
|
(190,102)
|
| Other comprehensive income (loss) |
(992)
|
|
|
(992)
|
|
|
|
(992)
|
| Stock-based compensation |
14,298
|
$ 7
|
14,291
|
|
|
|
|
14,298
|
| Stock-based compensation, shares |
|
676,325
|
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
1,546
|
$ 16
|
1,530
|
|
|
|
|
1,546
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
1,604,332
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(122)
|
|
|
|
$ (122)
|
|
|
(122)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
38,154
|
|
|
|
| Provision for common stock warrants |
5,247
|
|
5,247
|
|
|
|
|
5,247
|
| Additional paid-in capital due to contributions to consolidated VIE |
173
|
|
173
|
|
|
|
(173)
|
|
| Distributions to noncontrolling interest |
|
|
|
|
|
|
(16,474)
|
(16,474)
|
| Ending Balance at Jun. 30, 2026 |
581,753
|
$ 13,980
|
9,227,977
|
2,450
|
$ (3,104)
|
(8,659,550)
|
5,537
|
587,290
|
| Ending Balance, shares at Jun. 30, 2026 |
|
1,397,924,047
|
|
|
|
|
|
|
| Treasury Stock, Ending Balance, shares at Jun. 30, 2026 |
|
|
|
|
1,025,649
|
|
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
| Net income/(loss) |
99,766
|
|
|
|
|
99,766
|
(729)
|
99,037
|
| Other comprehensive income (loss) |
(1,185)
|
|
|
(1,185)
|
|
|
|
(1,185)
|
| Stock-based compensation |
12,722
|
$ 10
|
12,712
|
|
|
|
|
12,722
|
| Stock-based compensation, shares |
|
944,691
|
|
|
|
|
|
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards |
491
|
$ 11
|
480
|
|
|
|
|
491
|
| Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards, shares |
|
1,135,866
|
|
|
|
|
|
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards |
(1,479)
|
|
|
|
$ (1,479)
|
|
|
(1,479)
|
| Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards, shares |
|
|
|
|
703,502
|
|
|
|
| Provision for common stock warrants |
14,505
|
|
14,505
|
|
|
|
|
14,505
|
| Additional paid-in capital due to contributions to consolidated VIE |
(677)
|
|
(677)
|
|
|
|
677
|
|
| Ending Balance at Sep. 30, 2026 |
$ 705,896
|
$ 14,001
|
$ 9,254,997
|
$ 1,265
|
$ (4,583)
|
$ (8,559,784)
|
$ 5,485
|
$ 711,381
|
| Ending Balance, shares at Sep. 30, 2026 |
|
1,400,004,604
|
|
|
|
|
|
1,400,004,604
|
| Treasury Stock, Ending Balance, shares at Sep. 30, 2026 |
|
|
|
|
1,729,151
|
|
|
1,729,151
|